Impact News +++ Why Iovance Biotherapeutics Stock Was Climbing Today (Fool) +++ IOVANCE Aktie -3,21%

Gewinn & Umsatz News zur ILLUMINA Aktie

>ILLUMINA Aktienkurs

86.59 EUR +0.5% (Tradegate)

Ask: 87.47 EUR / 171 Stück

Bid: 87.02 EUR / 172 Stück

Tagesumsatz: 559 Stück

Realtime Kurs von 8 bis 22 Uhr!

ILLUMINA Aktie über LYNX handeln

Intraday

1 Jahr

>ILLUMINA Performance

1 Woche: +4,6%

1 Monat: +4,7%

3 Monate: +17,5%

6 Monate: -11,6%

1 Jahr: -29,4%

laufendes Jahr: -32,8%

>ILLUMINA Aktie

Name:

ILLUMINA INC. DL-,01

Land:

USA

Sektor:

Gesundheit

ISIN/ Wkn:

US4523271090 / 927079

Symbol/ Ticker:

ILU (Frankfurt) / ILMN (NASDAQ)

Kürzel:

FRA:ILU, ETR:ILU, ILU:GR, NASDAQ:ILMN

Index:

S&P500

Webseite:

http://www.illumina.com/

Profil:

Illumina, Inc. operates as a global leader in the ..
>Volltext..

Marktkapitalisierung:

13233.81 Mio. EUR

Unternehmenswert:

14457.23 Mio. EUR

Umsatz:

3667.43 Mio. EUR

EBITDA:

1228.19 Mio. EUR

Nettogewinn:

1077.45 Mio. EUR

Gewinn je Aktie:

6.79 EUR

Schulden:

2225.12 Mio. EUR

Liquide Mittel:

799.95 Mio. EUR

Operativer Cashflow:

988.37 Mio. EUR

Bargeldquote:

0.79

Umsatzwachstum:

-12.09%

Gewinnwachstum:

Dividende je Aktie:

Dividendenrendite:

Dividendenschätzung:

Insiderhandel:

Suchwörter:

ILLUMINA

Letzte Datenerhebung:

19.08.25

>ILLUMINA Kennzahlen

Aktien/ Unternehmen:

Aktien: 153.7 Mio. St.

Frei handelbar: 97.22%

Leerverk. Aktien: 4.88%

Rückkaufquote: 4.13%

Mitarbeiter: 10370

Umsatz/Mitarb.: 0.36 Mio. EUR

Analysten:

Analystenrating: Buy

Kursziel: 12.13%

Bewertung:

KGV: 12.71

KGV lG: 22.08

KUV: 3.65

KBV: 6.85

PEG-Ratio: -

EV/EBITDA: 11.77

Rentabilität:

Bruttomarge: 67.14%

Gewinnmarge: 29.38%

Operative Marge: 27%

Managementeffizenz:

Gesamtkaprendite: 20.68%

Eigenkaprendite: 68.11%

>ILLUMINA Peer Group

Es sind 601 Aktien bekannt.

>ILLUMINA Chart & Kurs - NASDAQ

>ILLUMINA Gewinn & Umsatz News

15.05.25 - 18:18

Quantum-Si (QSI) Earnings Coverage: Complete 1Q Coverage (24/7 Wall St.)

Live Updates Live Coverage Updates appear automatically as they are published. QSI Earnings Backdrop 11:26 am Quantum-Si operates at the intersection of biotech instrumentation and proteomics, targeting academic and pharma customers with novel single-molecule protein sequencing tech. The industry has seen strong interest in next-gen diagnostic platforms, but commercial adoption remains slow. Illumina's recent restructuring […] The post Quantum-Si (QSI) Earnings Coverage: Complete 1Q Coverage appeared first on 24/7 Wall St.....

10.03.25 - 23:12	Illumina Lowers FY25 Outlook Hurt By China Sales Ban (AFX)
	SAN DIEGO (dpa-AFX) - Illumina, Inc. (ILMN) responded on Monday to the notice from the China Ministry of Commerce stating that it is not permitted to export sequencing instruments into China. Illu......

10.03.25 - 21:06	Illumina to Cut $100 Million in Costs, Lowers Guidance Because of China Sales Ban (WSJ EN)
	Beijing banned imports of Illumina's gene-sequencing machines in response to U.S. tariffs....

06.02.25 - 22:30	Illumina Inc. Q4 Earnings Summary (AFX)
	SAN DIEGO (dpa-AFX) - Below are the earnings highlights for Illumina Inc. (ILMN):Earnings: $187 million in Q4 vs. -$176 million in the same period last year. EPS: $1.17 in Q4 vs. -$1.11 in the sam......

14.01.25 - 15:54	Illumina Boosts FY24 Outlook (AFX)
	SAN DIEGO (dpa-AFX) - Ahead of its presentation at the 43rd Annual J.P. Morgan Healthcare Conference later on Tuesday, Illumina, Inc. (ILMN) said it expects earnings in a range of approximately $0......

04.11.24 - 22:31	Illumina Inc. Q3 Earnings Summary (AFX)
	SAN DIEGO (dpa-AFX) - Below are the earnings highlights for Illumina Inc. (ILMN):Earnings: $705 million in Q3 vs. -$754 million in the same period last year. EPS: $4.42 in Q3 vs. -$4.77 in the sam......

07.08.24 - 02:21	Illumina Inc reports results for the quarter ended in June - Earnings Summary (Reuters EN)
	Illumina Inc reports results for the quarter ended in June - Earnings Summary...

07.08.24 - 01:04	Illumina expects full-year sales from core segment to decline on biotech funding crunch (Reuters EN)
	Illumina expects full-year sales from core segment to decline on biotech funding crunch...

06.08.24 - 22:36	Illumina Inc. Q2 Earnings Summary (AFX)
	SAN DIEGO (dpa-AFX) - Below are the earnings highlights for Illumina Inc. (ILMN):Earnings: -$1.988 billion in Q2 vs. -$234 million in the same period last year. EPS: -$12.48 in Q2 vs. -$1.48 in th......

>Impressum >Über uns >Datenschutz >Financial Data & Solutions

>Behalte deine Investments mit realtime Kursen & News im Blick. Finde neue spannende Aktien! Registriere Dich und werde Mitglied!

Zitat des Tages: Am Anfang war die Kraft. - Paula Modersohn-Becker

Partner: >Tradegate Börse | >Dukascopy | >Boersentreff- Partner

Börsentreff auf Facebook |

Börsentreff auf X |

Börsentreff auf Instagram